1,5-AG
Showing 26 - 50 of >10,000
Osteogenesis Imperfecta Trial in Ireland, United Kingdom (Teriparatide Pen Injector, Zoledronic Acid)
Recruiting
- Osteogenesis Imperfecta
- Teriparatide Pen Injector
- Zoledronic Acid
-
Dublin, Ireland
- +22 more
Mar 10, 2022
Duchenne Muscular Dystrophy Trial in Worldwide (ATL1102 25mg, ATL1102 50mg, Placebo)
Recruiting
- Duchenne Muscular Dystrophy
- ATL1102 25mg
- +2 more
-
Westmead, New South Wales, Australia
- +11 more
Jun 29, 2023
Secondary Progressive Multiple Sclerosis (SPMS) Trial in United Kingdom (Simvastatin, Placebo)
Active, not recruiting
- Secondary Progressive Multiple Sclerosis (SPMS)
- Simvastatin
- Placebo
-
Belfast, United Kingdom
- +23 more
Jul 4, 2022
First-line Treatment of Advanced Pancreatic Cancer Trial (HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate,
Not yet recruiting
- First-line Treatment of Advanced Pancreatic Cancer
- HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate
- nab-paclitaxel; gemcitabine
- (no location specified)
Feb 28, 2023
UK Infinity, Post-Market Clinical Follow-up Study
Active, not recruiting
- Arthritis, Rheumatoid
-
Torquay, Devon, United Kingdom
- +11 more
Feb 7, 2022
Anhydroglucitol in Children With Type 1 Diabetes
Not yet recruiting
- Diabetes Mellitus, Type 1
- Measurement of blood levels of 1,5-anhydroglucitol
- (no location specified)
Oct 25, 2022
A Study Looking at Ultrasound Guided Biopsies for Breast Cancer
Recruiting
- Breast Cancer
- Tumour bed core biopsy
-
Basildon, Essex, United Kingdom
- +15 more
Nov 29, 2021
Healthy Volunteers, Anemia, Sickle Cell Trial in Spain, United States (AG-946, AG-946 Matched Placebo)
Recruiting
- Healthy Volunteers
- Anemia, Sickle Cell
- AG-946
- AG-946 Matched Placebo
-
La Jolla, California
- +10 more
Jan 19, 2023
Neovascular (Wet) Age-related Macular Degeneration (AMD) Trial in United Kingdom (Stereotactic radiotherapy (16 Gray or Sham),
Active, not recruiting
- Neovascular (Wet) Age-related Macular Degeneration (AMD)
- Stereotactic radiotherapy (16 Gray or Sham)
- 0.5 mg ranibizumab
-
Huntingdon, Cambridgeshire, United Kingdom
- +29 more
Apr 1, 2022
Access HIV Ag/Ab Combo Assay - European Union Clinical Trial
Active, not recruiting
- HIV I Infection
- HIV-2 Infection
- Access HIV_blood donor
- +7 more
-
Bois-Guillaume, France
- +4 more
Jun 23, 2022
Healthy Trial in Ciudad de México (Tirfostina/L-Carnitina)
Enrolling by invitation
- Healthy
- Tirfostina/L-Carnitina
-
Ciudad de México, Azcapotzalco, MexicoPharmet, S.A de C.V.
Aug 2, 2022
Intracranial Hemorrhages, Intracranial Hemorrhage, Hypertensive, Subarachnoid Hemorrhage Trial in United Kingdom (Apixaban,
Completed
- Intracranial Hemorrhages
- +8 more
- Apixaban
- +6 more
-
Edinburgh, Midlothian, United Kingdom
- +66 more
Mar 31, 2022
Glioma Glioblastoma Multiforme Trial in United Kingdom (Standard of Care, Additional pre- and intra-operative imaging)
Recruiting
- Glioma Glioblastoma Multiforme
- Standard of Care
- Additional pre- and intra-operative imaging
-
Birmingham, United Kingdom
- +23 more
May 26, 2022
Diabetes, Metabolic Disease, Glucose Metabolism Disorders Trial in Bern (Device: Sokru device)
Active, not recruiting
- Diabetes Mellitus
- +3 more
- Device: Sokru device
-
Bern, SwitzerlandUniversity of Bern
Jun 26, 2023
Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Canada, United States (Enasidenib, Enasidenib
Recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Enasidenib
- Enasidenib Mesylate
-
Birmingham, Alabama
- +17 more
Jun 21, 2021
Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy Trial in Worldwide (Acoramidis (AG10))
Enrolling by invitation
- Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy
- Acoramidis (AG10)
-
Beverly Hills, California
- +104 more
Mar 21, 2022
Tumors Trial in Worldwide (Letetresgene autoleucel (lete-cel, GSK3377794), Fludarabine, Cyclophosphamide)
Active, not recruiting
- Neoplasms
- Letetresgene autoleucel (lete-cel, GSK3377794)
- +2 more
-
Duarte, California
- +36 more
Oct 28, 2022
Focal Epilepsy Trial run by the (Lu AG06466, Placebo)
Terminated
- Focal Epilepsy
- Lu AG06466
- Placebo
-
Bethesda, MarylandMid-Atlantic Epilepsy and Sleep Center
Nov 7, 2022
Breast Cancer, Estrogen Receptor Positive Tumor, HER2-positive Breast Cancer Trial in Worldwide (Paclitaxel, Trastuzumab,
Active, not recruiting
- Breast Cancer
- +2 more
- Paclitaxel
- +4 more
-
Brasschaat, Belgium
- +53 more
Nov 29, 2022
Triple Negative Breast Cancer, Hormone-Resistant Breast Cancer, Non Small Cell Lung Cancer Trial in Baltimore (AG-01 Compound)
Recruiting
- Triple Negative Breast Cancer
- +3 more
- AG-01 Compound
-
Baltimore, MarylandUniversity of Maryland Greenebaum Comprehensive Cancer Center
Nov 16, 2022
Leukemia, Myeloid, Isocitrate Dehydrogenase Trial in Worldwide (AG-221, BSC, Azacitidine)
Active, not recruiting
- Leukemia, Myeloid
- Isocitrate Dehydrogenase
- AG-221
- +4 more
-
Los Angeles, California
- +145 more
Jun 7, 2022
Oropharyngeal Cancer Trial in United Kingdom (Cisplatin, Durvalumab, Radiotherapy)
Recruiting
- Oropharyngeal Cancer
- Cisplatin
- +3 more
-
Exeter, Devon, United Kingdom
- +32 more
Nov 29, 2021